Summary
This prediction ended on 06.05.14 with a price of €3.63. With a performance of -9.80%, the BUY prediction for Evotec SE by Quitte closed slightly in the red. Quitte has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -3.233% | -3.233% | -64.953% | -84.701% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by Quitte for this prediction
In the thread Evotec AG diskutieren
gesunder Bio-Wert setzt wieder an
Der Absturz war vielleicht wirklich auf die Leerverkäufe zurück zu führen. Danke für die Info, theo7480!!
Oder der Trend der letzten Tage ging auch an Evotec nicht vorbei.
Jetzt wird wieder auf die Rippen geschlagen, was die Aktie die letzten Tage abgespeckt hat .